HomeInsightsMarket Capitalization

Market Capitalization of Neuland Laboratories Ltd

Market Capitalization of Neuland Laboratories Ltd

stocks purchased

₹ 2.3 Cr

Volume Transacted

(Dec 26, 2024)

stocks purchased

1.7 K

Stocks Traded

(Dec 26, 2024)

Last Updated on: Dec 26, 2024

Image

Neuland Laboratories Ltd

NSE: NEULANDLAB

Market Cap

₹ 17769.2 crore

Last updated on: Dec 24, 2024

Key Highlights

  • The Market Cap of Neuland Laboratories Ltd is ₹ 17769 crore as of 24 Dec 24 .
  • The Market Cap of Neuland Laboratories Ltd changed from ₹ 865.18 crore on March 2019 to ₹ 8058 crore on March 2024 . This represents a CAGR of 45.05% over 6 years.
  • The Latest Trading Price of Neuland Laboratories Ltd is ₹ 13446 as of 26 Dec 15:30 .
  • The Dividend Payouts of Neuland Laboratories Ltd changed from ₹ 2 on Feb 18, 2020 to ₹ 14 on Jul 12, 2024 . This represents a CAGR of 38.31% over 6 years.

Historical Market Cap of Neuland Laboratories Ltd

No data available

* All values are in crore

Company Fundamentals for Neuland Laboratories Ltd

No data available

Image

Neuland Laboratories Ltd

NSE: NEULANDLAB

Share Price

₹ 13446

-403.85 (-2.92%)

stock direction

Last updated on: Dec 26, 2024

Market Price of Neuland Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Neuland Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
24 Dec 202413849.85
23 Dec 202413807.75
20 Dec 202413901
19 Dec 202414429.95
18 Dec 202414795
17 Dec 202414762.05
16 Dec 202414835.35
13 Dec 202415313.8
12 Dec 202415974.75
11 Dec 202416948.65

SWOT Analysis Of Neuland Laboratories Ltd

Strength

5

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Neuland Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Neuland Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Neuland Laboratories Ltd

No data available

No data available

Historical P/E Ratio of Neuland Laboratories Ltd

No data available

* All values are in %

Historical Revenue of Neuland Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Neuland Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Neuland Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Neuland Laboratories Ltd

No data available

* All values are in

About Neuland Laboratories Ltd

  • Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao.
  • The Company is engaged in manufacturing and selling of bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin.
  • Neuland Drugs & Pharmaceuticals Pvt.
  • Ltd., a company set up by the same promoters to manufacture bulk drugs was merged with the Company effective from April, 1992.
  • NLL manufactures bulk drugs. The Company came out with its initial public offering in Apr.'94 at a premium of Rs 35 aggregating Rs 5.69 cr, to part-finance the capacity expansion to manufacture bulk drugs and to diversify its product-mix.

Neuland Laboratories Ltd News Hub

News

Neuland Laboratories Ltd leads losers in 'A' group

Hindustan Zinc Ltd, Five-Star Business Finance Ltd, Great Eastern Shipping Company Ltd and...

Read more

06 Nov 2024 15:00

News

Neuland Laboratories to declare Quarterly Result

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 6 Nov...

Read more

18 Oct 2024 09:43

News

Neuland Laboratories to hold board meeting

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 1 Aug...

Read more

18 Jul 2024 10:26

News

Neuland Laboratories AGM scheduled

Neuland Laboratories announced that the 40th Annual General Meeting(AGM) of the company wi...

Read more

11 May 2024 12:16

News

Board of Neuland Laboratories recommends Final Dividend

Neuland Laboratories announced that the Board of Directors of the Company at its meeting h...

Read more

10 May 2024 17:23

News

Neuland Laboratories schedules board meeting

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 10 Ma...

Read more

24 Apr 2024 11:24

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Neuland Laboratories Ltd Market Cap

What is the market cap of Neuland Laboratories Ltd?

As of December 26, 2024, Neuland Laboratories Ltd has a market capitalization of ₹17769.2, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Neuland Laboratories Ltd's market capitalization?

Neuland Laboratories Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Neuland Laboratories Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Neuland Laboratories Ltd's market capitalization change?

Neuland Laboratories Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions